Insights on Robotic Surgery, Innovation & Evolving Care in Prostate Cancer Treatment – 160

What if prostate cancer surgery meant fewer incisions, faster recovery, and more precise cancer control? Today I’m joined by Dr. Michael D. Stifelman, Chair of Urology at Hackensack University Medical Center and a pioneer in robotic surgery with 4,000+ robotic procedures. We unpack how single-port robotics, real-time margin assessment, and AI are reshaping outcomes—while protecting continence and erections.

Dr. Stifelman traces robotics from the early-2000s “pioneer phase” (and heavy skepticism) to today’s standard of care, explaining why reproducibility, visualization, and tissue-sparing dexterity made the difference. We compare surgery vs. radiation (and focal therapies), when each shines, and why sequencing often matters—especially in higher-risk disease. He shares emerging tech like single-port prostatectomy, intra-operative margin evaluation (e.g., Histo-style scanning), quantitative surgical analytics, and even remote robotic assistance. We also talk “trifecta” outcomes, the role of genomics in Gleason 7 decision-making, and why lifestyle medicine and optimizing the tumor micro-environment go hand-in-hand with any treatment.

Time-Stamped Highlights

00:00 – Why fewer incisions + faster recovery are now real in prostate surgery

05:40 – Work–life changes that improved health (sleep, exercise, biking)

09:10 – Open vs. robotic: why reproducibility (teachability) matters

11:05 – Robotics adoption curve: from early resistance to mainstream

19:05 – Outcomes today: continence and erections after modern surgery

20:10 – “Yes, I’m a surgeon—and here’s my bias.” Radical honesty with patients

22:05 – Offering the full menu: surveillance, focal (HIFU/cryotherapy), surgery, SBRT, proton

25:40 – High-risk (Gleason 8–9): why surgery-first can preserve options & avoid long ADT

34:00 – Dexterity & visualization: why robots spare nerves with less trauma

35:10 – Real-time margin assessment during surgery to reduce positives

40:00 – The “trifecta” (cancer control, continence, erections) and patient priorities

42:10 – Genomics to risk-stratify Gleason 7 and guide surveillance vs. treatment

45:00 – Future: nerve activation mapping & fluorescence to “light up” cancer

46:10 – Single-port prostatectomy: smaller access, faster return of function (select patients)

49:00 – Quantifying surgery with analytics; tele-mentoring & remote console potential

52:30 – How to find Dr. Stifelman & closing advice

👉 View complete episode show notes, resources, and transcript at DrGeo.com

___________________________________

🌱 Partner Offers

ProLon 5-Day Fasting Mimicking Diet — Enjoy fasting benefits with food. Supports cellular renewal, metabolic health, and fat loss. Special offer for our listeners: Get the ProLon kit for $148 → https://bit.ly/3TVehAx

AG1 by Athletic Greens — 75 high-quality vitamins, minerals, probiotics, and adaptogens in one daily scoop. Supports gut health, immunity, energy, and focus. Try it here → https://bit.ly/3mA2tVV

___________________________________

💪 Exclusive Membership

Want deeper insights? Join The Dr. Geo Prostate Podcast Exclusive Membership for curated transcripts, detailed show notes, expert resources, and member perks. → https://drgeo.com/membership

___________________________________

📌 Follow and Connect

📺 YouTube → Dr. Geo Prostate Podcast — https://www.youtube.com/@DrGeoProstatePodcast

🎧 All Episodes → Captivate.fm Archive — https://dr-geo-prostate-podcast.captivate.fm

📸 Instagram → https://bit.ly/DRGEO-INSTA-YT

📘 Facebook → https://bit.ly/POD-FB-DrGeo

💼 LinkedIn → https://bit.ly/DRGEO-LINKEDIN-YT

🛒 Supplements → XY Wellness https://bit.ly/3uJPC7Z | Mr. Happy https://bit.ly/3TE7tWE

🌐 DrGeo.com Website →...